TABLE 3.
Comparisons of brain pathology findings based on SARS‐CoV‐2 proteins in COVID‐19 patients
| Brain pathology findings | SARS‐CoV−2 proteins | p value | ||
|---|---|---|---|---|
| Yes | No | |||
| Edema | Yes | 21/38 (55.3%) | 17/38 (44.7%) | <0.001 |
| No | 21/88 (23.9%) | 67/88 (76.1%) | ||
| Hypoxic‐ischemic lesions | Yes | 20/83 (24.1%) | 63/83 (75.9%) | 0.705 |
| No | 19/71 (26.8%) | 52/71 (73.2%) | ||
| Hemorrhagic lesions | Yes | 1/14 (7.1%) | 13/14 (92.9%) | 0.241 |
| No | 28/140 (20.0%) | 112/140 (80.0%) | ||
| Microgliosis | Yes | 17/100 (17.0%) | 83/100 (83.0%) | 0.429 |
| No | 12/54 (22.2%) | 42/54 (77.8%) | ||
| Astrogliosis | Yes | 17/107 (15.9%) | 90/107 (84.1%) | 0.159 |
| No | 12/47 (25.5%) | 35/47 (74.5%) | ||
| Inflammatory infiltrates | Yes | 17/108 (15.7%) | 91/108 (84.3%) | 0.133 |
| No | 12/46 (26.1%) | 34/46 (73.9%) | ||
Data are reported as number of patients (percent). p values were obtained using the Pearson χ2 test. Significant p values are bolded.